CRAIG ZYLKA: Open Payments
NPI 1417952953 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,778 in 75 payments from 17 companies in 2025. Trend: 2023 $1,119 · 2024 $2,095 · 2025 $1,778
Food & beverage: $1,778
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $476 |
| Novo Nordisk Inc | 9 | $224 |
| Amgen Inc. | 12 | $212 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $153 |
| PFIZER INC. | 8 | $153 |
| ABBVIE INC. | 5 | $116 |
| Lilly USA, LLC | 5 | $93 |
| Exact Sciences Corporation | 3 | $69 |
| Merck Sharp & Dohme LLC | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
Products named: AIRSUPRA, Kerendia, BREZTRI, Rybelsus, FARXIGA, EVENITY, VRAYLAR, MOUNJARO.
Industry payments across MD — which companies pay providers there.
